Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,109 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 35,109 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 08, 2024 Filed Aug 2, 2024 21:14 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 21 | $1.49 | $31.29 |
DisclosureSEC source: 0001214659-24-013685 · marketforms-66721.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,152 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 05, 2024 Filed Aug 2, 2024 21:14 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 21 | $1.50 | $31.50 |
DisclosureSEC source: 0001214659-24-013685 · marketforms-66721.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,131 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 03, 2024 Filed Aug 2, 2024 21:14 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 26 | $1.52 | $39.52 |
DisclosureSEC source: 0001214659-24-013685 · marketforms-66721.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,110 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 02, 2024 Filed Aug 2, 2024 21:14 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 21 | $1.48 | $31.08 |
DisclosureSEC source: 0001214659-24-013685 · marketforms-66721.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,084 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| July 01, 2024 Filed Aug 2, 2024 21:14 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 21 | $1.47 | $30.87 |
DisclosureSEC source: 0001214659-24-013685 · marketforms-66721.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,063 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 20 | $1.50 | $30.00 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,042 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 27, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 21 | $1.52 | $31.92 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,022 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 26, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 21 | $1.50 | $31.50 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,001 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 25, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 21 | $1.54 | $32.34 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,980 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 24, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 21 | $1.59 | $33.39 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,959 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 21, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.49 | $61.09 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,938 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 20, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.53 | $62.73 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,897 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 18, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.57 | $64.37 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,856 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 17, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 41 | $1.49 | $61.09 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,815 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 14, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 48 | $1.50 | $72.00 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,774 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 13, 2024 Filed Jul 2, 2024 21:33 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.52 | $38.00 |
DisclosureSEC source: 0001214659-24-011873 · marketforms-66487.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,726 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 00:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $1.71 | $1,710.00 |
DisclosureSEC source: 0001214659-24-005221 · marketforms-65374.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,701 F1 · shares: Restricted stock award will vest 100% on March 25, 2025. Read SEC document |
| March 25, 2024 Filed Jan 30, 2025 21:37 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 2,500 | $1.71 | $4,275.00 |
DisclosureSEC source: 0001628280-25-003181 · wk-form4a_1738273036.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,318 F1 · shares: This amendment is being filed solely to correct an administrative error in reporting the number of Securities Acquired by Reporting Owner on the original Form 4 submitted on March 26, 2024, which were reported as 1,000 shares granted on March 25, 2024, but should have been reported as 2,500 shares. This reflects an increase of 1,500 shares. Read SEC document |
| December 21, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 87 | $1.70 | $147.90 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,701 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 20, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 124 | $1.76 | $218.24 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,614 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 19, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 81 | $1.73 | $140.13 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,490 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 18, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 81 | $1.80 | $145.80 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,409 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 15, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 82 | $1.89 | $154.98 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,328 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 14, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 82 | $1.86 | $152.52 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,246 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 13, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 82 | $1.80 | $147.60 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,164 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 12, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 87 | $1.77 | $153.99 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,082 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 11, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 82 | $1.85 | $151.70 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,995 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 08, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.83 | $131.76 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,913 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 07, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 34 | $1.65 | $56.10 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,841 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 06, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.70 | $122.40 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,807 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 05, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.69 | $121.68 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,735 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 04, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 64 | $1.72 | $110.08 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,663 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 01, 2023 Filed Dec 28, 2023 22:10 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.69 | $121.68 |
DisclosureSEC source: 0001214659-23-017033 · marketforms-63939.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,599 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 30, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 62 | $1.66 | $102.92 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,527 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 29, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 32 | $1.73 | $55.36 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,465 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 28, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.68 | $42.00 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,433 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 27, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.86 | $133.92 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,408 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 22, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.74 | $95.70 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,336 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 21, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.76 | $44.00 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,281 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 20, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 53 | $1.70 | $90.10 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,256 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 17, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.83 | $100.65 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,203 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 16, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $1.73 | $22.49 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,148 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 15, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.78 | $97.90 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,135 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 14, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.73 | $95.15 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,080 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 13, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 46 | $1.75 | $80.50 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,025 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 10, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.77 | $97.35 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,979 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 09, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.82 | $100.10 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,924 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 08, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.00 | $110.00 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,869 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 07, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 19 | $2.01 | $38.19 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,814 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 06, 2023 Filed Dec 6, 2023 22:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.03 | $111.65 |
DisclosureSEC source: 0001214659-23-016104 · marketforms-63726.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,795 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.